Insight Genetics gets $1.5M boost for lung cancer test

08/27/2013 | GenomeWeb Daily News (free registration)

Insight Genetics will use a $1.5 million grant from the National Cancer Institute to further develop its nonsmall-cell lung cancer diagnostic test. Specifically, Insight said it will develop a panel of tests for detecting and characterizing oncogenic DEPDC1, RET and ROS1 in NSCLC patients who have tested triple negative for KRAS, EGFR or ALK gene mutations.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA